Ontario cancer patients speak out over disappointment with drug funding decision
Sabrina Apitz-Grossman, 31, was told she has 12 to 18 months to live with synovial sarcoma that spread to her lungs; her doctors recommend Tecelra, a US-approved treatment costing $727,000 US, but OHIP denied out-of-country coverage and her appeal and case-by-case application both failed. After a court ordered coverage for another patient in July, Ontario changed the rules so out-of-country drug treatments are funded only if already funded in the province and temporarily unavailable.
The rule change closes the route other patients used to get life-extending treatment abroad when Ontario does not fund it.
Read the original
News source: Ontario cancer patients speak out over disappointment with drug funding decision (opens in a new tab) — CBC News
This summary was written by AI from the source’s published text and was not checked by a person before publication. If it disagrees with the source, the source is right.